14-23419961-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PP2PP3_Moderate
The NM_000257.4(MYH7):c.3610G>C(p.Gly1204Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000436 in 1,607,200 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000257.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151702Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249474Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135000
GnomAD4 exome AF: 0.00000412 AC: 6AN: 1455498Hom.: 0 Cov.: 35 AF XY: 0.00000415 AC XY: 3AN XY: 723350
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151702Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74070
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Gly1204Arg variant in MYH7 has been reported in at least 1 individual with hypertrophic cardiomyopathy (LMM Data, Homberger 2016 PMID 27247418), and has also been identified in 1/112264 of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID 52136). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2. -
Congenital myopathy with fiber type disproportion;C1834481:Dilated cardiomyopathy 1S;C1842160:Myosin storage myopathy;C1850709:Myopathy, myosin storage, autosomal recessive;C3495498:Hypertrophic cardiomyopathy 1;C4552004:MYH7-related skeletal myopathy Uncertain:1
- -
not provided Uncertain:1
Reported in association with HCM in the published literaure (Homburger et al., 2016); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27247418, 34542152) -
Hypertrophic cardiomyopathy Uncertain:1
This sequence change replaces glycine with arginine at codon 1204 of the MYH7 protein (p.Gly1204Arg). The glycine residue is moderately conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is not present in population databases (ExAC no frequency). This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 27247418). ClinVar contains an entry for this variant (Variation ID: 42966). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.G1204R variant (also known as c.3610G>C), located in coding exon 25 of the MYH7 gene, results from a G to C substitution at nucleotide position 3610. The glycine at codon 1204 is replaced by arginine, an amino acid with dissimilar properties. This variant has been detected in individuals from hypertrophic cardiomyopathy cohorts, and in a cohort not selected for the presence of cardiomyopathy; however, details were limited (Homburger JR et al. Proc Natl Acad Sci U S A, 2016 Jun;113:6701-6; Mademont-Soler I et al. PLoS One, 2017 Aug;12:e0181465; Park J et al. Hum Mol Genet, 2022 Mar;31:827-837). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at